Advances in antiviral vaccine development.

Advances in antiviral vaccine development.

Item
http://www.wikidata.org/entity/Q37292398
Immunity to viruses.Pediatric infectious diseases: getting research evidence into practice and generation of new evidence.Structural basis for the neutralization of hepatitis E virus by a cross-genotype antibody.The Non-structural Protein 5 and Matrix Protein Are Antigenic Targets of T Cell Immunity to Genotype 1 Porcine Reproductive and Respiratory Syndrome Viruses.Novel antigens for RSV vaccines.Challenges in Veterinary Vaccine Development and Immunization.Intradermal injection of an anti-Langerin-HIVGag fusion vaccine targets epidermal Langerhans cells in nonhuman primates and can be tracked in vivo.Computer aided epitope design as a peptide vaccine component against Lassa virus.Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic.Early Presence of HIV-1 Subtype C in Washington, D.CMulti-clade H5N1 virus-like particles: Immunogenicity and protection against H5N1 virus and effects of beta-propiolactonePhage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidates
P2860

Advances in antiviral vaccine development.

Item
http://www.wikidata.org/entity/Q37292398
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Advances in antiviral vaccine development.
@en
Advances in antiviral vaccine development.
@nl
type
label
Advances in antiviral vaccine development.
@en
Advances in antiviral vaccine development.
@nl
prefLabel
Advances in antiviral vaccine development.
@en
Advances in antiviral vaccine development.
@nl
P1433
P1476
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Advances in antiviral vaccine development.
@en
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932